PosiFunda · Fundamentals

Medexus Pharmaceuticals Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Medexus Pharmaceuticals Inc. made a loss over the last year.

Compared with Healthcare companies in Canada.

P/E ratio

Loss

Medexus Pharmaceuticals Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

2.32

The share price is 2.32 times Medexus Pharmaceuticals Inc.'s book value per share, higher than 52% of Healthcare companies in Canada.

Market cap

C$156 M

The total market value of all of Medexus Pharmaceuticals Inc.'s shares at today's price (share price × number of shares), larger than 73% of Healthcare companies in Canada. PosiCap size class: Mini Cap.

Return on equity (ROE)

-4.7%

Medexus Pharmaceuticals Inc. lost 4.7% of its shareholders' money over the last year, higher than 62% of Healthcare companies in Canada.

Dividend yield

None

Medexus Pharmaceuticals Inc. does not currently pay a dividend.

Questions

What is Medexus Pharmaceuticals Inc.'s return on equity?

Medexus Pharmaceuticals Inc. lost 4.7% of its shareholders' money over the last year, higher than 62% of Healthcare companies in Canada.

Does Medexus Pharmaceuticals Inc. pay a dividend?

No. Medexus Pharmaceuticals Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.